{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:07:45Z","timestamp":1781885265542,"version":"3.54.5"},"reference-count":32,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":124,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"UCB Pharma, Raleigh, NC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/ane.12414","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T11:29:01Z","timestamp":1430393341000},"page":"355-363","source":"Crossref","is-referenced-by-count":46,"title":["Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures"],"prefix":"10.1155","volume":"132","author":[{"given":"G. D.","family":"Rudd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Haverkamp","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Campus Virchow Clinic; Charite\u2032-University Medicine Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Mason","sequence":"additional","affiliation":[{"name":"Cardiology Division; Department of Medicine; University of Utah; Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wenger","sequence":"additional","affiliation":[{"name":"Wenger Consulting; Durham NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Jay","sequence":"additional","affiliation":[{"name":"RAPID Pharmaceuticals; Rockville MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hebert","sequence":"additional","affiliation":[{"name":"UCB Pharma; Raleigh NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Doty","sequence":"additional","affiliation":[{"name":"UCB Pharma; Raleigh NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Horstmann","sequence":"additional","affiliation":[{"name":"Consulting Early Development; Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"10.1111\/ane.12414-BIB0001|ane12414-cit-0001","first-page":"355","article-title":"Genetics of acquired long QT syndrome","volume":"132","author":"Roden","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1111\/ane.12414-BIB0002|ane12414-cit-0002","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","article-title":"Heart failure induced by non-cardiac drugs","volume":"29","author":"Slordal","year":"2006","journal-title":"Drug Saf"},{"key":"10.1111\/ane.12414-BIB0003|ane12414-cit-0003","unstructured":"ICH Guidance for Industry. E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm073153.pdf"},{"key":"10.1111\/ane.12414-BIB0004|ane12414-cit-0004","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0005|ane12414-cit-0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1167.2009.02496.x","article-title":"Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial","volume":"51","author":"Chung","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0006|ane12414-cit-0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial","volume":"50","author":"Hal\u00e1sz","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0007|ane12414-cit-0007","unstructured":"VIMPAT \u00ae . (lacosamide) Prescribing Information Smyrna, GA UCB Pharma 2014"},{"key":"10.1111\/ane.12414-BIB0008|ane12414-cit-0008","unstructured":"VIMPAT \u00ae . (lacosamide) Summary of Product Characteristics SA, Belgium UCB Pharma 2014"},{"key":"10.1111\/ane.12414-BIB0009|ane12414-cit-0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.107.039867","article-title":"The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels","volume":"73","author":"Errington","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1111\/ane.12414-BIB0010|ane12414-cit-0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jnr.23136","article-title":"Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation","volume":"91","author":"Niespodziany","year":"2013","journal-title":"J Neurosci Res"},{"key":"10.1111\/ane.12414-BIB0011|ane12414-cit-0011","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/0470846682.ch14","article-title":"Molecular mechanisms of gating and drug block of sodium channels","volume":"241","author":"Catterall","year":"2002","journal-title":"Novartis Found Symp"},{"key":"10.1111\/ane.12414-BIB0012|ane12414-cit-0012","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/978-1-84882-128-6_221","volume-title":"Atlas of Epilepsies","author":"Shah","year":"2010"},{"key":"10.1111\/ane.12414-BIB0013|ane12414-cit-0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1365-2125.2010.03855.x","article-title":"Effect of lamotrigine on the PR interval in healthy subjects","volume":"71","author":"Dixon","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ane.12414-BIB0014|ane12414-cit-0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF00878554","article-title":"Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects","volume":"9","author":"Kenneback","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/ane.12414-BIB0015|ane12414-cit-0015","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12413","article-title":"Cardiac safety of lacosamide: the non-clinical perspective","author":"Delaunois","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12414-BIB0016|ane12414-cit-0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","article-title":"Die Systolendauer im Elektrokardiogramm bei normalen Menchen und bei Herzkranken","volume":"53","author":"Fridericia","year":"1920","journal-title":"Acta Med Scand"},{"key":"10.1111\/ane.12414-BIB0017|ane12414-cit-0017","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1177\/0091270011426875","article-title":"No pharmacokinetic interaction between lacosamide and valproic acid in healthy volunteers","volume":"52","author":"Cawello","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ane.12414-BIB0018|ane12414-cit-0018","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/ane.12414-BIB0019|ane12414-cit-0019","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0091270010391789","article-title":"Evaluation of eslicarbazepine acetate on cardiac repolarization in a thorough QT\/QTc study","volume":"52","author":"Vaz-Da-Silva","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ane.12414-BIB0020|ane12414-cit-0020","unstructured":"LYRICA \u00ae . (pregabalin) CV Prescribing Information New York, NY Pfizer 2012"},{"key":"10.1111\/ane.12414-BIB0021|ane12414-cit-0021","doi-asserted-by":"crossref","DOI":"10.1111\/ane.12416","article-title":"Cardiac safety of lacosamide: a thorough QT\/QTc trial in healthy volunteers","author":"Kropeit","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12414-BIB0022|ane12414-cit-0022","unstructured":"UCB PHARMA Lacosamide Development Safety Update Report Number 4 for the Period 01-Sept-2013 to 31-Aug-2014"},{"key":"10.1111\/ane.12414-BIB0023|ane12414-cit-0023","first-page":"113","article-title":"Long-term non-interventional study of lacosamide safety as add-on therapy in patients with epilepsy and uncontrolled partial-onset seizures","volume":"55","author":"Steinhoff","year":"2014","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0024|ane12414-cit-0024","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1528-1167.2009.02463.x","article-title":"Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures","volume":"51","author":"Krauss","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0025|ane12414-cit-0025","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/j.1528-1167.2011.03212.x","article-title":"Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy","volume":"52","author":"Nizam","year":"2011","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0026|ane12414-cit-0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ebcr.2012.10.001","article-title":"Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy","volume":"1","author":"Degiorgio","year":"2013","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1111\/ane.12414-BIB0027|ane12414-cit-0027","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/epi.12108","article-title":"Sinus node dysfunction: an adverse effect of lacosamide","volume":"54","author":"Chinnasami","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12414-BIB0028|ane12414-cit-0028","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yebeh.2010.04.043","article-title":"Atrial flutter\/atrial fibrillation associated with lacosamide for partial seizures","volume":"18","author":"Degiorgio","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12414-BIB0029|ane12414-cit-0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ebcr.2012.10.006","article-title":"Low-dose lacosamide-induced atrial fibrillation: case analysis with literature review","volume":"1","author":"Kaufman","year":"2013","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1111\/ane.12414-BIB0030|ane12414-cit-0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.yebeh.2011.02.006","article-title":"Atrioventricular block following lacosamide intoxication","volume":"20","author":"Krause","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12414-BIB0031|ane12414-cit-0031","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yebeh.2014.05.015","article-title":"Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study","volume":"36","author":"Garces","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12414-BIB0032|ane12414-cit-0032","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1017\/S1047951114001188","article-title":"Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks","volume":"25","author":"Loomba","year":"2015","journal-title":"Cardiol Young"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12414","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12414\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:48:24Z","timestamp":1671540504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12414","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}